By Dr Matthew Gibson

Journal articles

Menzies SW; Sinz C; Menzies M; Lo SN; Yolland W; Lingohr J; Razmara M; Tschandl P; Guitera P; Scolyer RA; Boltz F; Borik-Heil L; Herbert Chan H; Chromy D; Coker DJ; Collgros H; Eghtedari M; Corral Forteza M; Forward E; Gallo B; Geisler S; Gibson M; Hampel A; Ho G; Junez L; Kienzl P; Martin A; Moloney FJ; Regio Pereira A; Ressler JM; Richter S; Silic K; Silly T; Skoll M; Tittes J; Weber P; Weninger W; Weiss D; Woo-Sampson P; Zilberg C; Kittler H, 2023, 'Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial', The Lancet Digital Health, 5, pp. e679 - e691, http://dx.doi.org/10.1016/S2589-7500(23)00130-9

Ho G; Gibson M; Kazemikhoo N; Murrell DF, 2022, 'Long-term follow-up of epidermolysis bullosa in real practice shows stability of the Epidermolysis Bullosa Disease Activity and Scarring Index and improvement with some off-label therapies', JAAD International, 9, pp. 105 - 107, http://dx.doi.org/10.1016/j.jdin.2022.07.008

Flora A; Gibson M; Toon C; Rawson R; Lowe P, 2022, 'Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum', Indian Journal of Dermatology, Venereology and Leprology, 88, pp. 90 - 92, http://dx.doi.org/10.25259/IJDVL_296_2021

Gibson M; Scolyer RA; Soyer HP; Ferguson P; McGeechan K; Irwig L; Bell KJL, 2021, 'Estimating the potential impact of interventions to reduce over-calling and under-calling of melanoma', Journal of the European Academy of Dermatology and Venereology, 35, pp. 1519 - 1527, http://dx.doi.org/10.1111/jdv.17189

Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF, 2021, 'A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', JAAD International, 2, pp. 134 - 152, http://dx.doi.org/10.1016/j.jdin.2020.12.007

Rogers C; Gibson M; Kern JS; Martin LK; Robertson SJ; Su JC; Daniel BS; Murrell DF, 2021, '157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Journal of Investigative Dermatology, 141, pp. S28 - S28, http://dx.doi.org/10.1016/j.jid.2021.02.177

Gibson M; Lowe PM, 2020, 'Considerations in pre-treatment testing for Strongyloides stercoralis in an Australian cohort of 159 patients receiving biological therapies', Australasian Journal of Dermatology, 61, pp. 378 - 379, http://dx.doi.org/10.1111/ajd.13317

Gibson M; Rogers CL; Murrell DF, 2020, 'Successful dapsone therapy in inherited epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 34, pp. e333 - e334, http://dx.doi.org/10.1111/jdv.16301

Gibson M; Murrell DF, 2020, 'Drug-related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma', Australasian Journal of Dermatology, 61, pp. 176 - 177, http://dx.doi.org/10.1111/ajd.13205

Gibson M; Murrell DF; Daniel BS, 2019, 'Mycobacterium chelonae infection mimicking demodex folliculitis.', Clin Exp Dermatol, http://dx.doi.org/10.1111/ced.14132

Gibson M; Murrell D, 2019, 'Is it psoriasis, a virus, or fungal infection?', Australian Doctor

Titov N; Gibson MB; Andrews G; Mcevoy PM, 2009, 'Internet treatment for social phobia reduces comorbidity', Australian and New Zealand Journal of Psychiatry, 43, pp. 754 - 759

Back to profile page